Green tea and the risk of prostate cancer
暂无分享,去创建一个
Xinghuan Wang | Ping Chen | Xinhua Zhang | Yuming Guo | Q. Mao | H. Xiang | F. Zhi | K. Zhao
[1] Xinghuan Wang,et al. Lycopene and Risk of Prostate Cancer , 2015, Medicine.
[2] M. S. Butt,et al. Green Tea and Anticancer Perspectives: Updates from Last Decade , 2015, Critical reviews in food science and nutrition.
[3] Michael J. Schell,et al. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention , 2015, Cancer Prevention Research.
[4] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[5] Hongqian Guo,et al. The association of tea consumption and the risk and progression of prostate cancer: a meta-analysis. , 2014, International journal of clinical and experimental medicine.
[6] Jia He,et al. Tea consumption and the risk of five major cancers: a dose–response meta-analysis of prospective studies , 2014, BMC Cancer.
[7] Xiangyi Zheng,et al. Tea consumption and prostate cancer: an updated meta-analysis , 2014, World Journal of Surgical Oncology.
[8] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[9] M. Bendahmane,et al. Association of diet with the risk of prostate cancer in Western Algeria , 2012, Oncologie.
[10] A. Huntley,et al. Green tea and green tea catechin extracts: an overview of the clinical evidence. , 2012, Maturitas.
[11] Jian-Min Yuan,et al. Green and black tea intake in relation to prostate cancer risk among Singapore Chinese , 2012, Cancer Causes & Control.
[12] Nicola Orsini,et al. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. , 2012, American journal of epidemiology.
[13] Ju-Sheng Zheng,et al. Green Tea and Black Tea Consumption and Prostate Cancer Risk: An Exploratory Meta-Analysis of Observational Studies , 2011, Nutrition and cancer.
[14] Jian-Min Yuan,et al. Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers. , 2010, International journal of molecular epidemiology and genetics.
[15] I. Kapetanovic,et al. Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs. , 2009, Toxicology.
[16] Chih-Pin Chuu,et al. Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. , 2009, Cancer letters.
[17] J. Holly,et al. Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin‐3‐gallate (EGCG) or an IGF‐i receptor inhibitor , 2009, The Prostate.
[18] U. Das,et al. Epigallocatechin-3-gallate affects the growth of LNCaP cells via membrane fluidity and distribution of cellular zinc , 2009, Journal of Zhejiang University SCIENCE B.
[19] G. Ferraro,et al. Total polyphenol content and antioxidant capacity of commercially available tea (Camellia sinensis) in Argentina. , 2008, Journal of agricultural and food chemistry.
[20] F. Rizzi,et al. Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. , 2008, European urology.
[21] Z. Asghar,et al. Evaluation of antioxidant properties of silymarin and its potential to inhibit peroxyl radicals in vitro. , 2008, Pakistan journal of pharmaceutical sciences.
[22] V. Adhami,et al. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis , 2008, Oncogene.
[23] Manami Inoue,et al. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. , 2007, American journal of epidemiology.
[24] Jun Wang,et al. Epigallocatechin‐3‐Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: Mechanisms of action , 2007, The Prostate.
[25] Andy H. Lee,et al. Tea and lycopene protect against prostate cancer. , 2007, Asia Pacific journal of clinical nutrition.
[26] S. Kuriyama,et al. No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study , 2006, British Journal of Cancer.
[27] V. Adhami,et al. Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. , 2006, Carcinogenesis.
[28] Giovanni Castagnetti,et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. , 2006, Cancer research.
[29] Ian M Thompson,et al. Mechanisms of Disease: prostate cancer—a model for cancer chemoprevention in clinical practice , 2005, Nature Clinical Practice Oncology.
[30] C. Belluco,et al. Prostate carcinoma and green tea: PSA‐triggered basement membrane degradation and MMP‐2 activation are inhibited by (−)epigallocatechin‐3‐gallate , 2004, International journal of cancer.
[31] A. Albini,et al. Prostate carcinoma and green tea: (−)epigallocatechin‐3‐gallate inhibits inflammation‐triggered MMP‐2 activation and invasion in murine TRAMP model , 2004, International journal of cancer.
[32] V. Adhami,et al. Oral Consumption of Green Tea Polyphenols Inhibits Insulin-Like Growth Factor-I–Induced Signaling in an Autochthonous Mouse Model of Prostate Cancer , 2004, Cancer Research.
[33] A. Roddam,et al. A prospective study of diet and prostate cancer in Japanese men , 2004, Cancer Causes & Control.
[34] N. Miyanaga,et al. A case‐control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet , 2004, Cancer science.
[35] Andy H. Lee,et al. Protective effect of green tea against prostate cancer: A case‐control study in southeast China , 2004, International journal of cancer.
[36] D. Boothman,et al. Synthesis and Functional Analyses of Nuclear Clusterin, a Cell Death Protein* , 2003, The Journal of Biological Chemistry.
[37] B. Frei,et al. Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions , 2003, Critical reviews in food science and nutrition.
[38] Aslamuzzaman Kazi,et al. Inhibition of Bcl-XL Phosphorylation by Tea Polyphenols or Epigallocatechin-3-Gallate Is Associated with Prostate Cancer Cell Apoptosis , 2002 .
[39] Aslamuzzaman Kazi,et al. Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis. , 2002, Molecular pharmacology.
[40] Shaobo Zhang,et al. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells , 2000, Oncogene.
[41] R. Hiipakka,et al. Printed in U.S.A. Copyright © 2000 by The Endocrine Society Modulation of Endocrine Systems and Food Intake by , 2022 .
[42] Bettuzzi Saverio,et al. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. , 2000 .
[43] S. Bettuzzi,et al. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. , 2000, Cancer research.
[44] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[45] R. Hiipakka,et al. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. , 1995, Cancer letters.
[46] R. Hiipakka,et al. Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. , 1995, Biochemical and biophysical research communications.
[47] S. Greenland,et al. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. , 1992, American journal of epidemiology.
[48] I Yoshimura,et al. The effect of measurement error on the dose-response curve. , 1990, Environmental health perspectives.
[49] S Greenland,et al. Quantitative methods in the review of epidemiologic literature. , 1987, Epidemiologic reviews.
[50] J. Clarke,et al. Medicine , 1907, Bristol medico-chirurgical journal.